A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2019
At a glance
- Drugs Serlopitant (Primary)
- Indications Pruritus
- Focus Registrational; Therapeutic Use
- Sponsors Menlo Therapeutics
- 15 Jan 2019 According to a Menlo Therapeutics media release, data from the trial is expected by the first quarter of 2020.
- 08 Nov 2018 New source identified and integrated (European Clinical Trials Database: EudraCT2017-004210-25)
- 17 Sep 2018 According to a Menlo Therapeutics media release, results from this trial is expected in the first half of 2020.